Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Phaos Technology Holdings Cayman Cash-to-Debt?
Phaos Technology Holdings CaymanPOAS +0.47%4 Cash-to-Debt is 0.35 as of Oct. 2025, which is 29% below its 10-year median of 0.49. GuruFocus rates POAS with a GF Score™ of 4/100. The stock has 5 warning signs investors should review. Among 801 Medical Devices & Instruments companies, Phaos Technology Holdings Cayman ranks worse than 76.65% on this metric.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Phaos Technology Holdings Cayman's cash to debt ratio for the quarter that ended in Oct. 2025 was 0.35.
If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Phaos Technology Holdings Caymancouldn't pay off its debt using the cash in hand for the quarter that ended in Oct. 2025.
The historical rank and industry rank for Phaos Technology Holdings Cayman's Cash-to-Debt or its related term are showing as below:
POAS'
s Cash-to-Debt Range Over the Past 10 Years
Min: 0.06 Med: 0.49 Max: 2.92
Current: 0.35
During the past 3 years, Phaos Technology Holdings Cayman's highest Cash to Debt Ratio was 2.92. The lowest was 0.06. And the median was 0.49.
POAS's Cash-to-Debt is ranked worse than 76.65% of 801
companies
in the Medical Devices & Instruments industry
Industry Median: 1.68
vs POAS: 0.35
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
Phaos Technology Holdings Cayman Cash-to-Debt Related Terms
Phaos Technology Holdings Cayman Cash-to-Debt Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Medical Devices subindustry, Phaos Technology Holdings Cayman's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Phaos Technology Holdings Cayman Cash-to-Debt vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Phaos Technology Holdings Cayman's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where Phaos Technology Holdings Cayman's Cash-to-Debt falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Phaos Technology Holdings Cayman (POAS) has a Cash-to-Debt of 0.35 as of Oct. 2025. This is 29% below median its historical median of 0.49. Over the past decade, Phaos Technology Holdings Cayman's Cash-to-Debt has ranged from 0.06 to 2.92. According to the industry distribution chart, Phaos Technology Holdings Cayman ranks #614 out of 801 companies in the Medical Devices & Instruments industry, placing it in the top 76.7%.
Is Phaos Technology Holdings Cayman's Cash-to-Debt too high?
Phaos Technology Holdings Cayman's current Cash-to-Debt of 0.35 is 29% below median its 10-year median of 0.49. Over the past 10 years, this metric has ranged from a low of 0.06 to a high of 2.92. The Medical Devices & Instruments industry median Cash-to-Debt is 1.68. Phaos Technology Holdings Cayman's value of 0.35 is 79.2% below this industry median. Based on the distribution chart, Phaos Technology Holdings Cayman ranks #614 out of 801 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Phaos Technology Holdings Cayman has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Phaos Technology Holdings Cayman's Cash-to-Debt compare to XAIR and LUDG?
According to the Medical Devices & Instruments industry distribution chart, Phaos Technology Holdings Cayman ranks #614 out of 801 companies for Cash-to-Debt. This places Phaos Technology Holdings Cayman in the lower half of its industry. The industry median Cash-to-Debt is 1.68. Phaos Technology Holdings Cayman's value of 0.35 is 79.2% below this benchmark. Historically, Phaos Technology Holdings Cayman's own Cash-to-Debt has ranged from 0.06 to 2.92 over the past decade. While the company's 10-year median is 0.49 vs. the industry median of 1.68, Phaos Technology Holdings Cayman has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Medical Devices & Instruments company?
The median Cash-to-Debt among Medical Devices & Instruments companies is 1.68, based on 801 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Phaos Technology Holdings Cayman's current Cash-to-Debt of 0.35 is 79.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Cash-to-Debt is 1.68 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Phaos Technology Holdings Cayman's current Cash-to-Debt is 0.35, which is 29% below median its own 10-year median of 0.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phaos Technology Holdings Cayman stock overvalued right now?
Phaos Technology Holdings Cayman (POAS) has a current Cash-to-Debt of 0.35. The current Cash-to-Debt is 0.35, which is 29% below median its 10-year median of 0.49 and 79.2% below the Medical Devices & Instruments industry median of 1.68. Phaos Technology Holdings Cayman's overall GF Score™ is 4/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For Phaos Technology Holdings Cayman (POAS), the current Cash-to-Debt is 0.35 as of Oct. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Phaos Technology Holdings Cayman Ltd is an investment holding company incorporated in the Cayman Islands. Through its subsidiaries, the Company engages in the research, development, manufacturing, and commercialization of advanced optical technologies and products. Leveraging its patented microsphere technology, Phaos enhances the magnification of traditional optical microscopes, enabling visualization beyond the 200nm optical limit at a commercially viable working distance. The Company offers advanced microscopy equipment and parts, along with AI-powered software solutions that complement its hardware to deliver fully integrated microscopy systems. Its technologies serve diverse sectors, including manufacturing, biomedical, and research.
4GF Score
Get the complete analysis for POAS
Cash-to-Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
POAS has been successfully added to your 
